Prostate Cancer

News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.

62-year-old with serum PSA level of 4.11 ng/mL. Prostate MRI shows lesion in left mid anterior transition zone
News | Prostate Cancer
PI-RADS 2.0 vs. 2.1—Prostate Cancer Upgrade, Downgrade Rates

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
Patients treated with IMRT had lower rates of toxicity to lungs and less radiation to the heart compared to conventional chemoradiation
News | Radiation Oncology
Intensity-modulated Radiation Therapy Provides Long-term Benefits to Patients with Locally Advanced Lung Cancer

September 13, 2023 — Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients ...

Time September 13, 2023
arrow
Michael J. Zelefsky, MD, a renowned leader in radiation oncology, is joining NYU Langone’s Perlmutter Cancer Center as director of brachytherapy and vice chair for academic and faculty affairs
News | Radiation Oncology
Renowned Radiation Oncologist Joins NYU Langone’s Perlmutter Cancer Center as Vice Chair for Academic and Faculty Affairs, Director of Brachytherapy

September 12, 2023 — Michael J. Zelefsky, MD, a renowned leader in radiation oncology, is joining NYU Langone’s ...

Time September 12, 2023
arrow
Using MRI as a screening test alongside PSA density allowed detection of cancers that would have been missed by the blood test alone, according to new research from UCL, UCLH and King’s College London
News | Prostate Cancer
MRI Scans Improve Prostate Cancer Diagnosis in Screening Trial

August 22, 2023 — Using MRI as a screening test alongside PSA density allowed detection of cancers that would have been ...

Time August 22, 2023
arrow
The multi-arm study will utilize Paige Prostate Detect, the only FDA approved AI in pathology for detecting prostate cancer
News | Digital Pathology
Paige and Ohio State Wexner Medical Center Collaborate to Study How AI Tools Can Bring Accuracy and Efficiency to Prostate Cancer Diagnosis in a Community Hospital Setting

August 21, 2023 — Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications that ...

Time August 21, 2023
arrow
In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid in therapy selection without the need for a biopsy
News | Prostate Cancer
PSMA PET/CT Waives the Need for Pre-imaging Biopsy in Elderly Patients

August 15, 2023 — In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid ...

Time August 15, 2023
arrow
FDA-approved in May 2023, POSLUMA is commercially available through 36 radiopharmacies across the United States
News | Prostate Cancer
Blue Earth Diagnostics Announces Addition of POSLUMA (Flotufolastat F 18) Injection to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer

July 28, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 28, 2023
arrow
Researchers at Monash University have designed a new co-training AI algorithm for medical imaging that can effectively mimic the process of seeking a second opinion.
News | PET Imaging
PSMA PET Imaging Improves Accuracy of Predicting Prostate Cancer Recurrence

July 26, 2023 — A molecular imaging tool developed by researchers at the University of California’s two nationally ...

Time July 26, 2023
arrow
A technique that uses imaging technology as a guide can make radiation therapy safer for patients with prostate cancer by helping clinicians accurately aim radiation beams at the prostate while avoiding nearby tissue in the bladder, urethra, and rectum.
News | Prostate Cancer
Image-guided Adaptive Radiation Treatments Reduce Short-term Side Effects for Patients with Prostate Cancer

July 24, 2023 — A technique that uses imaging technology as a guide can make radiation therapy safer for patients with ...

Time July 24, 2023
arrow
Guerbet, a global specialist in contrast media and medical imaging solutions, announced the success of its teams at the PI-CAI (Prostate Imaging: Cancer Al) Grand Challenge
News | Prostate Cancer
Guerbet Wins PI-CAI Grand Challenge on Detection of Prostate Cancer

July 19, 2023 — Guerbet, a global specialist in contrast media and medical imaging solutions, announced the success of ...

Time July 19, 2023
arrow
Radformation, a leader in cancer care clinical and operational software solutions, announced that BVP Forge has made a strategic investment in the company to accelerate its global growth.
News | Radiation Oncology
Radformation Partners with BVP Forge to Accelerate AI-Driven Solutions for Cancer Care

July 12, 2023 — Radformation, a leader in cancer care clinical and operational software solutions, announced that BVP ...

Time July 12, 2023
arrow
In an attempt to ease cancer treatment and control the spread of disease across other parts of the body, radiotherapy is expected to emerge as a viable solution; however, with radiotherapy side effects growing, the industry is set to unleash a new potential in cancer care
Feature | Radiation Therapy | By Vinisha Joshi
Radiotherapy Challenges and Opportunities to Consider in 2023

The rising prevalence of cancers calls for a diverse set of treatment services. According to the American Cancer Society ...

Time July 11, 2023
arrow
City of Hope researchers establish foundation to expand SCINTIX therapy using a prostate cancer-specific PET radiotracer
News | Prostate Cancer
RefleXion Highlights Clinical Study Results for Future Prostate Cancer Treatment

July 3, 2023 — RefleXion Medical, Inc., a therapeutic oncology company, today announced that results of a prospective ...

Time July 03, 2023
arrow
News | SNMMI
Prostate Cancer Treatment Study at SNMMI 2023 Finds Improved Patient Outcomes with Personalized Dosing

June 29, 2023 — A study presented this week during the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) ...

Time June 29, 2023
arrow
The integration of its advanced AIR technologies with the SIGNA PET/MR AIR system, to enhance diagnostic precision, simplify treatment evaluation, while elevating patient comfort
News | SNMMI
GE HealthCare Advances PET/MR Capabilities with AIR Technologies

June 28, 2023 — GE HealthCare is set to unveil SIGNA PET/MR AIR[i], at the Society of Nuclear Medicine and Molecular ...

Time June 28, 2023
arrow
A newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake, sustained tumor retention, and high contrast in preclinical models, making it a prime candidate for a novel theranostics approach
News | SNMMI
Novel Theranostic Agent Targets Multiple Cancer Types

June 28, 2023 — A newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake ...

Time June 28, 2023
arrow
POSLUMA is now commercially available in multiple U.S. radiopharmacies, with nationwide availability by end of June 2023
News | Prostate Cancer
Blue Earth Diagnostics and PETNET Solutions Inc, A Siemens Healthineers Company, Announce U.S. Commercial Availability of POSLUMA (Flotufolastat F 18) Injection for PET Imaging of Prostate Cancer

June 21, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time June 21, 2023
arrow
The study found considerable promise for Avenda Health’s machine learning model, Unfold AI, showing it to be effective in encapsulating all of the clinically significant cancer within the prostate (80%) over current standard of care (56%)
News | Artificial Intelligence
New Stanford Research Study Provides Further Evidence for Personalized Prostate Cancer Mapping Using Machine Learning

June 14, 2023 —Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, today ...

Time June 14, 2023
arrow
POSLUMA (flotufolastat F 18) PET/CT image showing uptake in the prostate gland, consistent with primary prostate cancer Photo courtesy of Blue Earth Diagnostics
News | Radiopharmaceuticals and Tracers
U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

May 30, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time May 30, 2023
arrow
RaySearch Laboraties AB (publ) announces that Yonsei Cancer Center in South Korea has treated its first patient using RayStation and RayCare for carbon ion radiation therapy
News | Radiation Therapy
RayStation and RayCare in Clinical Use with Carbon Ions at Yonsei Cancer Center in South Korea

May 30, 2023 — The first treatment, for a patient with prostate cancer, was successfully carried out on April 28. Yonsei ...

Time May 30, 2023
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now